Literature DB >> 28623443

Autolyse the cell in order to save it? Inducing, then blocking, autolysis as a strategy for delaying cell death in the probiotic Lactobacillus reuteri.

Tahl Zimmerman1,2, Rabin Gyawali3, Salam Ibrahim3.   

Abstract

OBJECTIVE: To examine whether choline and its derivatives can be used to preserve viable cells of Lactobacillus reuteri in autolytic models.
RESULTS: A phosphate-induced autolytic model in de Man, Rogosa and Sharpe medium (MRS) was used. Viable cell counts were determined by plated on MRS-agar. Choline and hemicholinium-3 (HC-3) significantly blocked autolysis of L. reuteri at 360 mM and 4 mM, respectively. Viable cell counts corroborated these observations. Importantly, autolytically induced cells treated with choline and hemicholinium-3 were significantly more viable then even non-induced cells. Over-production of a known autolytic protein, spirosin, was not attenuated in the presence of choline and hemicholinium-3.
CONCLUSION: Inducing autolysis and then blocking it with choline and its analogs is a promising approach for retaining the viability of L. reuteri cells.

Entities:  

Keywords:  Autolysis; Functional foods; Lactobacillus; Probiotics; Viability

Mesh:

Substances:

Year:  2017        PMID: 28623443     DOI: 10.1007/s10529-017-2380-8

Source DB:  PubMed          Journal:  Biotechnol Lett        ISSN: 0141-5492            Impact factor:   2.461


  5 in total

1.  Choline Kinase, A Novel Drug Target for the Inhibition of Streptococcus pneumoniae.

Authors:  Tahl Zimmerman; Salam Ibrahim
Journal:  Antibiotics (Basel)       Date:  2017-09-25

2.  Choline Kinase Emerges as a Promising Drug Target in Gram-Positive Bacteria.

Authors:  Tahl Zimmerman; Juan Carlos Lacal; Salam A Ibrahim
Journal:  Front Microbiol       Date:  2019-10-15       Impact factor: 5.640

3.  Autolysis and Cell Death Is Affected by pH in L. reuteri DSM 20016 Cells.

Authors:  Tahl Zimmerman; Salam A Ibrahim
Journal:  Foods       Date:  2021-05-09

4.  Identification and validation of novel and more effective choline kinase inhibitors against Streptococcus pneumoniae.

Authors:  Tahl Zimmerman; Valerie Chasten; Juan Carlos Lacal; Salam A Ibrahim
Journal:  Sci Rep       Date:  2020-09-22       Impact factor: 4.379

Review 5.  Choline Kinase: An Unexpected Journey for a Precision Medicine Strategy in Human Diseases.

Authors:  Juan Carlos Lacal; Tahl Zimmerman; Joaquín M Campos
Journal:  Pharmaceutics       Date:  2021-05-25       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.